We have cocrystallized the drug ethidium bromide with the dinucleoside monophosphate 5-iodouridylyl(3'-5')adenosine and have solved the three-dimensional structure to atomic resolution by x-ray crystallography. This has allowed the direct visualization of intercalative binding by this drug to a fragment of a nucleic acid double helix.Ethidium bromide is one in a class of phenanthridinium drugs that has been found to be useful in the treatment of certain trypanosome infections (1). See Fig. 1. Its medicinal action stems from the ability of the drug to bind to DNA and RNA and to inhibit nucleic acid function (2, 3). The precise nature of ethidium binding to nucleic acids has been the object of study by many workers over the years (3)(4)(5)(6)(7)(8)(9). It is generally thought that ethidium binds to DNA (and perhaps to RNA) through intercalation in much the same manner as that postulated for the aminoacridines (10, 11). Evidence for this has been advanced by means of a variety of physical techniques. Viscometric and hydrodynamic measurements with linear DNA molecules indicate a lengthening and stiffening of the helix in the presence of increasing concentrations of the drug (3), an interpretation directly supported by electron microscopic measurements (4). The ability of this drug to unwind circular supercoiled DNA is also considered to be another sensitive criteria for intercalative binding (5, 6). This is thought to reflect unwinding of the DNA helix by the drug at the immediate site of intercalation. The enhancement of fluorescence and a red shift in the ethidium absorption spectrum accompany the binding reaction (7,8). These spectral perturbations are most easily explained by the stacking of the phenanthridinium ring system on the nucleic acid base pairs. Fiber x-ray diffraction studies have been carried out on the complex, and a tentative molecular model for ethidium-DNA interaction has been proposed (9).We have previously reported the successful cocrystallization of ethidium with several self-complementary dinucleoside monophosphates (12). We have now solved the three-dimensional structure of one of these [ethidium: 5-iodouridylyl(3'- 5')adenosine] to atomic resolution by x-ray crystallography. This has allowed us to directly visualize intercalative binding by this drug to a fragment of a nucleic acid double helix. MATERIALS AND METHODSEthidium bromide was purchased from Sigma Chemical Co. and used without further purification. The dinucleoside monophosphates uridylyl(3'-5')adenosine (U-A) and cytidylyl(3'-5')guanosine (C-G), were obtained as the ammonium salts from Sigma Chemical Co. and used directly. Iodination of both dinucleoside monophosphates was accomplished through use of a synthesis devised by Prof. David C. Ward and his colleagues at Yale University. The dinucleoside monophosphates were first converted to a stable mercury intermediate by incubating with mercuric acetate for several hours at 50'C, pH 5.5, in 0.1 M sodium acetate buffer (13). This intermediate was then reacted with elemental i...
Ten xanthene dyes (XAN) are evaluated for their ability to potentiate the antiviral activity of poly r(A-U) using a human foreskin fibroblast-vesicular stomatitis virus bioassay in which the XAN is combined with 0.2 mM poly r(A-U) to produce a XAN/ribonucleotide ratio of 1/4. Four of the ten XANs tested in this study, rhodamine 123, rhodamine B, rhodamine 6G and sulforhodamine B, enhance the antiviral activity of poly r(A-U) 8- to 15-fold. The interferon-inducing activity of the four active XAN/poly r(A-U) combinations is equal to the sum of the activities of their constituents. These four XANs appear to potentiate the antiviral activity of the poly r(A-U) without superinduction of interferon. The direct viral inactivation study demonstrates that the XANs, poly r(A-U) and the XAN/poly r(A-U) combinations do not inactivate the VSV at concentrations near the 50% effective dose.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.